XML 108 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 10, 2024
Sep. 28, 2023
Mar. 07, 2023
Jan. 22, 2021
Feb. 24, 2020
Mar. 24, 2020
May 31, 2024
May 31, 2023
Apr. 20, 2023
May 21, 2021
Jan. 21, 2021
Jul. 21, 2020
Feb. 29, 2020
Dec. 31, 2017
Dec. 31, 2014
Subsidiary, Sale of Stock [Line Items]                              
Sale of stock, net proceeds             $ 10,014,000              
Sale of stock expenses     $ 700,000                        
Shelf registration statement maximum authorized common stock issuance value $ 5,500,000 $ 20,000,000   $ 15,000,000                      
Preferred stock, par value             $ 0 $ 0              
Common Stock [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Conversion of stock, shares issued           250,000                  
Conversion of stock, shares issued upon conversion                     321,429 571,429      
Series A Preferred Stock [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Preferred stock, shares issued             0 0              
Preferred stock, par value             $ 0.08 $ 0.08              
ATM Offering [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Sale of stock expenses               $ 53,000              
Common Stock [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Sale of stock shares issued     3,333,333                        
Sale of stock, price per share     $ 2.40                        
Sale of stock, net proceeds     $ 7,300,000                        
Common Stock [Member] | ATM Offering [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Preferred stock, purchase price               $ 2,014,000              
Sale of stock shares issued               573,889              
Sale of stock, net proceeds               $ 1,961,000              
Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Conversion of stock, shares converted           250,000                  
Convertible Preferred Stock [Member] | Stock Purchase Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Preferred stock, purchase price         $ 2,000,000                    
Sale of stock, price per share         $ 3.50                    
Preferred stock, shares issued         571,429                    
Preferred stock, par value         $ 0.08                    
Dividends payable, amount per share         $ 0.175                    
Maximum [Member] | Common Stock [Member] | ATM Offering [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Sale of stock, price per share               $ 4.26              
Maximum [Member] | Common Stock [Member] | ATM Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Preferred stock, purchase price       $ 15,000,000                      
Minimum [Member] | Common Stock [Member] | ATM Offering [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Sale of stock, price per share               3.15              
Share-Based Payment Arrangement, Option [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Vesting period             4 years                
Award purchase price, percent             80.00%                
Expiration period             10 years                
Granted, weighted average grant date fair value             $ 0.80 $ 2.19              
Compenation cost related to non-vested stock option             $ 1,265,000                
Weighted average period expected term             2 years 4 months 13 days                
Exercisable weighted average remaining contractual term             4 years 11 months 19 days                
Vested, exercisable or expected to vest weighted average remaining contractual term             6 years 7 months 13 days                
Share-Based Payment Arrangement, Option [Member] | 2014 Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share-based payment award, number of shares authorized                             850,000
Share-Based Payment Arrangement, Option [Member] | 2017 Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share-based payment award, number of shares authorized                           900,000  
Share-Based Payment Arrangement, Option [Member] | 2020 Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share-based payment award, number of shares authorized                         900,000    
Share-Based Payment Arrangement, Option [Member] | 2023 Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share-based payment award, number of shares authorized                 1,200,000            
2020 Stock Incentive Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share-based payment award, number of shares authorized                   900,000